RHD remains a major public health concern in many parts of the world. According to the World Health Organization (WHO), there are approximately 39 million people affected by RHD globally, with the highest prevalence in sub-Saharan Africa, South Asia, and certain parts of the Pacific. It disproportionately affects women and young people, leading to significant morbidity and mortality.
